Real-time diagnosis of cancer involved sentinel lymph nodes (SLNS) based on pH sensing
A method for detecting cancer involved lymph nodes. The method includes placing a pH-sensing paper inside a needle of an injection syringe, filling the injection syringe with a buffer solution, putting the pH-sensing paper in contact with lymphatic fluid of a lymph node by inserting the needle of the injection syringe inside the lymph node, putting the lymphatic fluid in interaction with the buffer solution by injecting the buffer solution into the lymph node utilizing the injection syringe, and detecting that the lymph node as a cancer involved lymph node if color of the pH-sensing paper is changed to an acidic-range pH color.
1. A method for detecting cancer involved lymph nodes, comprising:
in vivo measuring pH value of lymphatic fluid of a lymph node, comprising:
placing a pH-sensing paper inside a hollow needle of an injection syringe by adhering the pH-sensing paper inside the hollow needle, one end of the pH-sensing paper at a tip of the hollow needle being in contact with a surrounding environment of the hollow needle;
filling the injection syringe with a buffer solution;
putting the pH-sensing paper in in-situ contact with lymphatic fluid of the lymph node inside the lymph node by putting the one end of the pH-sensing paper inside the lymph node via inserting the tip of the hollow needle of the injection syringe inside the lymph node; and
putting the lymphatic fluid in interaction with the buffer solution by injecting the buffer solution through the hollow needle of the injection syringe into the lymph node utilizing the injection syringe, the interacted lymphatic fluid of the lymph node with the buffer solution being in contact with the one end of the pH-sensing paper; and
detecting the lymph node being a cancer involved lymph node responsive to the measured pH value of the lymphatic fluid of the lymph node being less than 7.0 by detecting changing color of the pH-sensing paper to an acidic-range pH color.
2. The method of claim 1 , wherein injecting the buffer solution into the lymph node comprises injecting a sterile buffer solution of phosphate-buffered saline (PBS) into the lymph node.
3. The method of claim 2 , wherein injecting the sterile buffer solution into the lymph node comprises injecting at least 100 μL of the sterile buffer solution of PBS into the lymph node.
4. The method of claim 1 , wherein injecting the buffer solution into the lymph node comprises injecting the buffer solution into a lymph node located at least one of armpits, digestive system, groin, neck, and combinations thereof.
5. The method of claim 1 , wherein injecting the buffer solution into the lymph node comprises at least one of in vitro injecting the buffer solution into the lymph node and in vivo injecting the buffer solution into the lymph node.
6. The method of claim 1 , wherein detecting the lymph node being a cancer involved lymph node comprises:
detecting changes in color of the pH-sensing paper for a time period between 5 seconds and 30 seconds after injecting the buffer solution into the lymph node; and
detecting the lymph node being a cancer involved lymph node responsive to detecting a change in color of the pH-sensing paper to an acidic-range pH color.
7. The method of claim 1 , wherein the needle of the injection syringe comprises a hypodermic needle with a gauge size 18.
8. The method of claim 1 , wherein injecting the buffer solution into the lymph node comprises injecting a biocompatible sterile buffer solution with a neutral pH value into the lymph node.
9. The method of claim 1 , wherein detecting the lymph node being a cancer involved lymph node comprises detecting the lymph node being a cancer involved lymph node responsive to the measured pH value of the lymphatic fluid of the lymph node being less than 6.0.